Cargando…
Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?
SIMPLE SUMMARY: Traditional therapeutic approaches to esophageal adenocarcinoma involve a combination of surgery, chemotherapy, and radiation. Despite innovations in treatment, outcomes remain poor. Targeted molecular therapies and immunotherapies have been used to great effect in various other soli...
Autores principales: | Khalafi, Shayan, Lockhart, Albert Craig, Livingstone, Alan S., El-Rifai, Wael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690268/ https://www.ncbi.nlm.nih.gov/pubmed/33105560 http://dx.doi.org/10.3390/cancers12113077 |
Ejemplares similares
-
Advances in targeted therapies and new promising targets in esophageal cancer
por: Belkhiri, Abbes, et al.
Publicado: (2015) -
Unfolded Protein Response Is Activated by Aurora Kinase A in Esophageal Adenocarcinoma
por: Lu, Heng, et al.
Publicado: (2022) -
Quantification of Esophageal Angulation in Sigmoid Achalasia: Are We There Yet?
por: Nabi, Zaheer, et al.
Publicado: (2020) -
Treat-to-Target in Axial Spondyloarthritis: Are we there yet?
por: Aouad, Krystel, et al.
Publicado: (2022) -
Integrated molecular analysis reveals complex interactions between genomic and epigenomic alterations in esophageal adenocarcinomas
por: Peng, DunFa, et al.
Publicado: (2017)